Figure 3.
Depsipeptide causes increased 1D10 antigen expression in vivo. Before and 24 hours following treatment with 13 mg/m2 depsipeptide of a patient with CLL, peripheral mononuclear cells were isolated and analyzed simultaneously for surface expression of CD19 and the HLA-DR antigen 1D10.
